Insider · CIK 0002004141
Xinyan Hao
Files at GCT (GigaCloud Technology Inc). First filing Sep 30, 2025, latest Sep 30, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
GCT: GigaCloud Technology Inc
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 16Weak | GigaCloud Technology Inc | $413k 13,742 shares | -2% | +154% from low-9% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 29, 2025 | GCT GigaCloud Technology Inc | SOpen-market sale Class A Ordinary Shares, par value $0.05 per shareindirect: By ICEBERY LIMITED10b5-1 | -13,742 | $30.02 | $413k | 793,744 | Sep 30, 2025 |
| Apr 10, 2025 | GCT GigaCloud Technology Inc | AGrant or award Class A Ordinary Shares, par value $0.05 per shareindirect: By ICEBERY LIMITED | +7,500 | $0.00 | $0 | 794,986 | Apr 11, 2025 |
| Apr 10, 2025 | GCT GigaCloud Technology Inc | MOption exercise Class A Ordinary Shares, par value $0.05 per shareindirect: By ICEBERY LIMITED | +12,500 | $0.00 | $0 | 807,486 | Apr 11, 2025 |
| Apr 10, 2025 | GCT GigaCloud Technology Inc | AGrant or award Restricted Share Unitsderivativeindirect: By ICEBERY LIMITED | +7,500 | $0.00 | $0 | 20,000 | Apr 11, 2025 |
| Apr 10, 2025 | GCT GigaCloud Technology Inc | MOption exercise Restricted Share Unitsderivativeindirect: By ICEBERY LIMITED | -12,500 | $0.00 | $0 | 7,500 | Apr 11, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.